Paion AG PA8.DE Stock
Paion AG Price Chart
Paion AG PA8.DE Financial and Trading Overview
| Paion AG stock price | 0.36 EUR |
| Previous Close | 0.67 EUR |
| Open | 0.7 EUR |
| Bid | 0 EUR x 8200 |
| Ask | 0 EUR x 20000 |
| Day's Range | 0.63 - 6.74 EUR |
| 52 Week Range | 0.63 - 9.8 EUR |
| Volume | 21.47K EUR |
| Avg. Volume | 3.86K EUR |
| Market Cap | 48.08M EUR |
| Beta (5Y Monthly) | 1.45249 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.78 EUR |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 38.3 EUR |
PA8.DE Valuation Measures
| Enterprise Value | 50.46M EUR |
| Trailing P/E | N/A |
| Forward P/E | -13.48 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 1.4461362 |
| Price/Book (mrq) | 7.270766 |
| Enterprise Value/Revenue | 1.518 |
| Enterprise Value/EBITDA | 15.624 |
Trading Information
Paion AG Stock Price History
| Beta (5Y Monthly) | 1.45249 |
| 52-Week Change | 3.79% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.8 EUR |
| 52 Week Low | 0.63 EUR |
| 50-Day Moving Average | 5.99 EUR |
| 200-Day Moving Average | 6.68 EUR |
PA8.DE Share Statistics
| Avg. Volume (3 month) | 3.86K EUR |
| Avg. Daily Volume (10-Days) | 5.67K EUR |
| Shares Outstanding | 7.13M |
| Float | 6.48M |
| Short Ratio | N/A |
| % Held by Insiders | 8.00% |
| % Held by Institutions | 3.83% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | N/A |
| Last Split Factor | 0.1:1 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | December 31, 2022 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | -1.74% |
| Operating Margin (ttm) | 6.67% |
| Gross Margin | 89.69% |
| EBITDA Margin | 9.71% |
Management Effectiveness
| Return on Assets (ttm) | 3.70% |
| Return on Equity (ttm) | -8.50% |
Income Statement
| Revenue (ttm) | 33.25M EUR |
| Revenue Per Share (ttm) | 4.66 EUR |
| Quarterly Revenue Growth (yoy) | 369.69% |
| Gross Profit (ttm) | 31.75M EUR |
| EBITDA | 3.23M EUR |
| Net Income Avi to Common (ttm) | -579000 EUR |
| Diluted EPS (ttm) | -0.28 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 10.63M EUR |
| Total Cash Per Share (mrq) | 1.49 EUR |
| Total Debt (mrq) | 599K EUR |
| Total Debt/Equity (mrq) | 9.06 EUR |
| Current Ratio (mrq) | 1.414 |
| Book Value Per Share (mrq) | 0.927 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 5.94M EUR |
| Levered Free Cash Flow (ttm) | 3.55M EUR |
Profile of Paion AG
| Country | Germany |
| State | N/A |
| City | Aachen |
| Address | Heussstrasse 25 |
| ZIP | 52078 |
| Phone | 49 2414 4530 |
| Website | https://www.paion.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 70 |
Paion AG, a specialty pharmaceutical company, develops and commercializes drugs for hospital-based sedation, anesthesia, and intensive care medicine services worldwide. The company's lead product is Remimazolam, an ultra-short-acting intravenous benzodiazepine sedative/anesthetic, which is in clinical development for use in procedural sedation, general anesthesia, and intensive care unit sedation. It is also developing Angiotensin II, a vasoconstrictor indicated for the treatment of refractory hypotension in adults with septic or other distributive shock; and Eravacycline, a novel fluorocycline antibiotic indicated for the treatment of complicated intra-abdominal infections in adults. The company has partnerships and license agreements with Cosmo Pharmaceuticals, Hana Pharm, Yichang Humanwell, and Mundipharma. Paion AG was founded in 2000 and is based in Aachen, Germany.
Q&A For Paion AG Stock
What is a current PA8.DE stock price?
Paion AG PA8.DE stock price today per share is 0.36 EUR.
How to purchase Paion AG stock?
You can buy PA8.DE shares on the XETRA exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Paion AG?
The stock symbol or ticker of Paion AG is PA8.DE.
Which industry does the Paion AG company belong to?
The Paion AG industry is Biotechnology.
How many shares does Paion AG have in circulation?
The max supply of Paion AG shares is 7.53M.
What is Paion AG Price to Earnings Ratio (PE Ratio)?
Paion AG PE Ratio is now.
What was Paion AG earnings per share over the trailing 12 months (TTM)?
Paion AG EPS is -2.78 EUR over the trailing 12 months.
Which sector does the Paion AG company belong to?
The Paion AG sector is Healthcare.
Paion AG PA8.DE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| DAXSEC.PHA.+HEALTHC.PR CXKPX | 1902.7 EUR 2079.91 USD |
-0.26
|
— — | 1902.7 EUR 2079.91 USD | 1902.7 EUR 2079.91 USD | — - | — — |
| TECHN. ALL SHARE TR TECALL | 3949.51 EUR 4317.35 USD |
-0.53
|
— — | 3945.97 EUR 4313.48 USD | 4023.76 EUR 4398.51 USD | — - | — — |
| DAXSEC.PHA.+HEALTHC.TR CXPPX | 3558.78 EUR 3890.23 USD |
-0.26
|
— — | 3552.84 EUR 3883.73 USD | 3620.75 EUR 3957.97 USD | — - | — — |
| TECHN. ALL SHARE PR TECALLP | 2957.51 EUR 3232.96 USD |
-0.53
|
— — | 2954.86 EUR 3230.06 USD | 3013.11 EUR 3293.74 USD | — - | — — |
| PRIME ALL SH. TR PRIME | 7076.21 EUR 7735.25 USD |
-0.2
|
— — | 7051.99 EUR 7708.78 USD | 7173.11 EUR 7841.18 USD | — - | — — |
- {{ link.label }} {{link}}